PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
BLUE vs. NCSM
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between BLUE and NCSM is 0.09, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.0
Correlation: 0.1

Performance

BLUE vs. NCSM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in bluebird bio, Inc. (BLUE) and NCS Multistage Holdings, Inc. (NCSM). The values are adjusted to include any dividend payments, if applicable.

-100.00%-98.00%-96.00%-94.00%-92.00%-90.00%NovemberDecember2025FebruaryMarchApril
-99.64%
-92.84%
BLUE
NCSM

Key characteristics

Sharpe Ratio

BLUE:

-0.52

NCSM:

1.26

Sortino Ratio

BLUE:

-0.64

NCSM:

2.09

Omega Ratio

BLUE:

0.91

NCSM:

1.26

Calmar Ratio

BLUE:

-0.79

NCSM:

0.76

Martin Ratio

BLUE:

-1.34

NCSM:

7.15

Ulcer Index

BLUE:

58.84%

NCSM:

10.38%

Daily Std Dev

BLUE:

152.39%

NCSM:

59.21%

Max Drawdown

BLUE:

-99.88%

NCSM:

-98.58%

Current Drawdown

BLUE:

-99.86%

NCSM:

-94.70%

Fundamentals

Market Cap

BLUE:

$40.53M

NCSM:

$72.77M

EPS

BLUE:

-$24.84

NCSM:

$2.55

PEG Ratio

BLUE:

0.32

NCSM:

0.00

PS Ratio

BLUE:

0.48

NCSM:

0.45

PB Ratio

BLUE:

0.73

NCSM:

0.74

Total Revenue (TTM)

BLUE:

$65.23M

NCSM:

$118.90M

Gross Profit (TTM)

BLUE:

$1.72M

NCSM:

$46.01M

EBITDA (TTM)

BLUE:

-$108.13M

NCSM:

$9.60M

Returns By Period

In the year-to-date period, BLUE achieves a -50.36% return, which is significantly lower than NCSM's 10.32% return.


BLUE

YTD

-50.36%

1M

4.55%

6M

-57.82%

1Y

-79.71%

5Y*

-64.87%

10Y*

-45.53%

NCSM

YTD

10.32%

1M

-20.91%

6M

55.36%

1Y

75.71%

5Y*

19.96%

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

BLUE vs. NCSM — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BLUE
The Risk-Adjusted Performance Rank of BLUE is 1919
Overall Rank
The Sharpe Ratio Rank of BLUE is 2626
Sharpe Ratio Rank
The Sortino Ratio Rank of BLUE is 2323
Sortino Ratio Rank
The Omega Ratio Rank of BLUE is 2222
Omega Ratio Rank
The Calmar Ratio Rank of BLUE is 77
Calmar Ratio Rank
The Martin Ratio Rank of BLUE is 1717
Martin Ratio Rank

NCSM
The Risk-Adjusted Performance Rank of NCSM is 8787
Overall Rank
The Sharpe Ratio Rank of NCSM is 8989
Sharpe Ratio Rank
The Sortino Ratio Rank of NCSM is 8888
Sortino Ratio Rank
The Omega Ratio Rank of NCSM is 8585
Omega Ratio Rank
The Calmar Ratio Rank of NCSM is 8181
Calmar Ratio Rank
The Martin Ratio Rank of NCSM is 9292
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

BLUE vs. NCSM - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for bluebird bio, Inc. (BLUE) and NCS Multistage Holdings, Inc. (NCSM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for BLUE, currently valued at -0.52, compared to the broader market-2.00-1.000.001.002.003.00
BLUE: -0.52
NCSM: 1.33
The chart of Sortino ratio for BLUE, currently valued at -0.64, compared to the broader market-6.00-4.00-2.000.002.004.00
BLUE: -0.64
NCSM: 2.17
The chart of Omega ratio for BLUE, currently valued at 0.91, compared to the broader market0.501.001.502.00
BLUE: 0.91
NCSM: 1.28
The chart of Calmar ratio for BLUE, currently valued at -0.79, compared to the broader market0.001.002.003.004.00
BLUE: -0.79
NCSM: 0.81
The chart of Martin ratio for BLUE, currently valued at -1.34, compared to the broader market-5.000.005.0010.0015.0020.00
BLUE: -1.34
NCSM: 7.54

The current BLUE Sharpe Ratio is -0.52, which is lower than the NCSM Sharpe Ratio of 1.26. The chart below compares the historical Sharpe Ratios of BLUE and NCSM, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00NovemberDecember2025FebruaryMarchApril
-0.52
1.33
BLUE
NCSM

Dividends

BLUE vs. NCSM - Dividend Comparison

Neither BLUE nor NCSM has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

BLUE vs. NCSM - Drawdown Comparison

The maximum BLUE drawdown since its inception was -99.88%, roughly equal to the maximum NCSM drawdown of -98.58%. Use the drawdown chart below to compare losses from any high point for BLUE and NCSM. For additional features, visit the drawdowns tool.


-100.00%-98.00%-96.00%-94.00%-92.00%NovemberDecember2025FebruaryMarchApril
-99.86%
-94.70%
BLUE
NCSM

Volatility

BLUE vs. NCSM - Volatility Comparison

bluebird bio, Inc. (BLUE) and NCS Multistage Holdings, Inc. (NCSM) have volatilities of 28.09% and 26.88%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


0.00%20.00%40.00%60.00%80.00%100.00%NovemberDecember2025FebruaryMarchApril
28.09%
26.88%
BLUE
NCSM

Financials

BLUE vs. NCSM - Financials Comparison

This section allows you to compare key financial metrics between bluebird bio, Inc. and NCS Multistage Holdings, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab